Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALID I valacyclovir pediatric oral solution bioequivalence study
NL-OMON39942Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of valaciclovir in Varicella zoster infection and herpes simplex (HSV) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: AUC0-*, Cmax and 1 more. Started May 2013; status: active, not recruiting.
02
Drugs
valaciclovir
03
Conditions
Varicella zoster infectionherpes simplex (HSV)
Beyond the preview
Go deeper on NL-OMON39942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39942.